Shahswar R, Gabdoulline R, Krueger K, Wichmann M, et al. A novel prognostic risk model for patients with refractory/relapsed acute myeloid leukemia receiving venetoclax plus hypomethylating agents. Leukemia 2025 Jan 8. doi: 10.1038/s41375-024-02501.
PMID: 39779979